Annual CFI
-$141.64 M
-$134.30 M-1830.00%
December 31, 2023
Summary
- As of February 7, 2025, VYGR annual cash flow from investing activities is -$141.64 million, with the most recent change of -$134.30 million (-1830.00%) on December 31, 2023.
- During the last 3 years, VYGR annual CFI has fallen by -$254.64 million (-225.35%).
- VYGR annual CFI is now -225.35% below its all-time high of $113.00 million, reached on December 31, 2020.
Performance
VYGR Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$64.35 M
+$100.30 M+279.04%
September 30, 2024
Summary
- As of February 7, 2025, VYGR quarterly cash flow from investing activities is $64.35 million, with the most recent change of +$100.30 million (+279.04%) on September 30, 2024.
- Over the past year, VYGR quarterly CFI has increased by +$37.52 million (+139.82%).
- VYGR quarterly CFI is now -40.96% below its all-time high of $108.99 million, reached on March 31, 2020.
Performance
VYGR Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$40.82 M
+$222.66 M+84.51%
September 30, 2024
Summary
- As of February 7, 2025, VYGR TTM cash flow from investing activities is -$40.82 million, with the most recent change of +$222.66 million (+84.51%) on September 30, 2024.
- Over the past year, VYGR TTM CFI has increased by +$100.82 million (+71.18%).
- VYGR TTM CFI is now -125.36% below its all-time high of $160.97 million, reached on September 30, 2020.
Performance
VYGR TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VYGR Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1830.0% | +139.8% | +71.2% |
| 3 y3 years | -225.3% | +357.5% | -456.3% |
| 5 y5 years | -635.2% | +357.5% | -456.3% |
VYGR Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -314.9% | at low | at high | +140.7% | -161.9% | +84.5% |
| 5 y | 5-year | -225.3% | at low | -41.0% | +140.7% | -125.4% | +84.5% |
| alltime | all time | -225.3% | +27.3% | -41.0% | +140.7% | -125.4% | +84.5% |
Voyager Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $64.35 M(-279.0%) | -$40.82 M(-84.5%) |
| Jun 2024 | - | -$35.94 M(-62.6%) | -$263.48 M(+4.5%) |
| Mar 2024 | - | -$96.06 M(-458.0%) | -$252.20 M(+78.1%) |
| Dec 2023 | -$141.64 M(+1830.0%) | $26.83 M(-117.0%) | -$141.64 M(-8.3%) |
| Sep 2023 | - | -$158.30 M(+541.9%) | -$154.41 M(-499.8%) |
| Jun 2023 | - | -$24.66 M(-270.2%) | $38.62 M(+42.2%) |
| Mar 2023 | - | $14.49 M(+3.0%) | $27.15 M(-469.9%) |
| Dec 2022 | -$7.34 M(-111.1%) | $14.07 M(-59.5%) | -$7.34 M(-72.7%) |
| Sep 2022 | - | $34.72 M(-196.1%) | -$26.87 M(-43.1%) |
| Jun 2022 | - | -$36.13 M(+80.7%) | -$47.25 M(-518.8%) |
| Mar 2022 | - | -$20.00 M(+266.0%) | $11.28 M(-82.9%) |
| Dec 2021 | $65.91 M(-41.7%) | -$5.46 M(-138.1%) | $65.91 M(+32.2%) |
| Sep 2021 | - | $14.34 M(-36.0%) | $49.85 M(-20.7%) |
| Jun 2021 | - | $22.41 M(-35.3%) | $62.87 M(+62.8%) |
| Mar 2021 | - | $34.63 M(-260.9%) | $38.63 M(-65.8%) |
| Dec 2020 | $113.00 M(-224.9%) | -$21.52 M(-178.7%) | $113.00 M(-29.8%) |
| Sep 2020 | - | $27.36 M(-1588.4%) | $160.97 M(+3.0%) |
| Jun 2020 | - | -$1.84 M(-101.7%) | $156.23 M(+0.7%) |
| Mar 2020 | - | $108.99 M(+311.9%) | $155.18 M(-271.5%) |
| Dec 2019 | -$90.48 M | $26.46 M(+17.0%) | -$90.48 M(+2.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $22.61 M(-882.9%) | -$88.31 M(-21.2%) |
| Jun 2019 | - | -$2.89 M(-97.9%) | -$112.11 M(-33.5%) |
| Mar 2019 | - | -$136.66 M(-577.3%) | -$168.60 M(-737.0%) |
| Dec 2018 | $26.47 M(-819.0%) | $28.63 M(-2499.8%) | $26.47 M(-142.5%) |
| Sep 2018 | - | -$1.19 M(-98.0%) | -$62.26 M(-2.5%) |
| Jun 2018 | - | -$59.37 M(-201.7%) | -$63.84 M(-287.4%) |
| Mar 2018 | - | $58.40 M(-197.2%) | $34.07 M(-1025.5%) |
| Dec 2017 | -$3.68 M(-107.7%) | -$60.10 M(+2071.3%) | -$3.68 M(-108.6%) |
| Sep 2017 | - | -$2.77 M(-107.2%) | $42.70 M(-18.0%) |
| Jun 2017 | - | $38.53 M(+86.6%) | $52.08 M(-7.5%) |
| Mar 2017 | - | $20.66 M(-250.5%) | $56.31 M(+18.0%) |
| Dec 2016 | $47.72 M(-124.5%) | -$13.72 M(-307.5%) | $47.72 M(-225.1%) |
| Sep 2016 | - | $6.61 M(-84.5%) | -$38.13 M(-31.0%) |
| Jun 2016 | - | $42.76 M(+254.3%) | -$55.26 M(-69.7%) |
| Mar 2016 | - | $12.07 M(-112.1%) | -$182.55 M(-6.3%) |
| Dec 2015 | -$194.77 M(+5798.5%) | -$99.58 M(+847.2%) | -$194.77 M(+104.6%) |
| Sep 2015 | - | -$10.51 M(-87.6%) | -$95.19 M(+12.4%) |
| Jun 2015 | - | -$84.53 M(>+9900.0%) | -$84.68 M(>+9900.0%) |
| Mar 2015 | - | -$150.00 K | -$150.00 K |
| Dec 2014 | -$3.30 M | - | - |
FAQ
- What is Voyager Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Voyager Therapeutics?
- What is Voyager Therapeutics annual CFI year-on-year change?
- What is Voyager Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Voyager Therapeutics?
- What is Voyager Therapeutics quarterly CFI year-on-year change?
- What is Voyager Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Voyager Therapeutics?
- What is Voyager Therapeutics TTM CFI year-on-year change?
What is Voyager Therapeutics annual cash flow from investing activities?
The current annual CFI of VYGR is -$141.64 M
What is the all time high annual CFI for Voyager Therapeutics?
Voyager Therapeutics all-time high annual cash flow from investing activities is $113.00 M
What is Voyager Therapeutics annual CFI year-on-year change?
Over the past year, VYGR annual cash flow from investing activities has changed by -$134.30 M (-1830.00%)
What is Voyager Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of VYGR is $64.35 M
What is the all time high quarterly CFI for Voyager Therapeutics?
Voyager Therapeutics all-time high quarterly cash flow from investing activities is $108.99 M
What is Voyager Therapeutics quarterly CFI year-on-year change?
Over the past year, VYGR quarterly cash flow from investing activities has changed by +$37.52 M (+139.82%)
What is Voyager Therapeutics TTM cash flow from investing activities?
The current TTM CFI of VYGR is -$40.82 M
What is the all time high TTM CFI for Voyager Therapeutics?
Voyager Therapeutics all-time high TTM cash flow from investing activities is $160.97 M
What is Voyager Therapeutics TTM CFI year-on-year change?
Over the past year, VYGR TTM cash flow from investing activities has changed by +$100.82 M (+71.18%)